153 related articles for article (PubMed ID: 7176091)
1. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
[No Abstract] [Full Text] [Related]
2. [Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].
Sezaki T; Ishii H; Adachi T; Takahashi I; Ohnoshi T; Kimura I
Rinsho Ketsueki; 1983 Apr; 24(4):433-9. PubMed ID: 6887543
[No Abstract] [Full Text] [Related]
3. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
[No Abstract] [Full Text] [Related]
4. Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy.
Adachi T; Asano K; Sezaki T; Takahashi I; Kimura I
Acta Med Okayama; 1982 Feb; 36(1):39-47. PubMed ID: 7064732
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
[No Abstract] [Full Text] [Related]
6. "Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
Manoharan A
Eur J Haematol; 1990 Nov; 45(5):274-5. PubMed ID: 2261956
[No Abstract] [Full Text] [Related]
7. [Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period].
Mizuno H; Ninomiya N; Ohta H; Tokoro K; Yasuma A; Ohnishi K; Ikeda Y
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2286-91. PubMed ID: 6639091
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
Kamiya O; Hoshino A; Ohara K; Nagata K; Ono Y; Saito M; Itou T; Yamamoto K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):863-5. PubMed ID: 2469398
[No Abstract] [Full Text] [Related]
9. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
Hara M; Nakamura T; Fujii Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
11. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
[No Abstract] [Full Text] [Related]
12. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
[TBL] [Abstract][Full Text] [Related]
14. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.
Kanamaru R; Wakui A; Ishioka C; Okuno M; Konishi Y; Ishikawa A; Shibata H
Sci Rep Res Inst Tohoku Univ Med; 1988 Dec; 35(1-4):35-40. PubMed ID: 3267125
[No Abstract] [Full Text] [Related]
16. [Therapy of paraproteinemic hemoblastoses].
Fereberger W
Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
[TBL] [Abstract][Full Text] [Related]
17. [Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
Furukawa K; Fujiwara Y; Nakaide Y; Tanaka M; Tanaka M; Hirota Y
Rinsho Ketsueki; 1980 Nov; 21(11):1683-91. PubMed ID: 6782278
[No Abstract] [Full Text] [Related]
18. [The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients].
Katsadze IuL; Bessmel'tsev SS; Abdulkadyrov KM
Ter Arkh; 1991; 63(7):61-4. PubMed ID: 1788812
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.
Ishii H
Acta Med Okayama; 1988 Jun; 42(3):175-82. PubMed ID: 3165236
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of four-drug combination treatment of adriamycin, vincristine, ifosfamide, and prednisolone for patients with malignant lymphoma, especially relapsed or refractory types (author's transl)].
Kimura I; Ohnoshi T; Oka A; Nakata Y; Hayashi K; Sato M; Nishihara R; Tanaka T; Sezaki T
Rinsho Ketsueki; 1980 Jun; 21(6):785-91. PubMed ID: 7463736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
